![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 18956 |
FusionGeneSummary for KIT_HOPX |
![]() |
Fusion gene information | Fusion gene name: KIT_HOPX | Fusion gene ID: 18956 | Hgene | Tgene | Gene symbol | KIT | HOPX | Gene ID | 3815 | 84525 |
Gene name | KIT proto-oncogene receptor tyrosine kinase | HOP homeobox | |
Synonyms | C-Kit|CD117|PBT|SCFR | CAMEO|HOD|HOP|LAGY|NECC1|OB1|SMAP31|TOTO | |
Cytomap | 4q12 | 4q12 | |
Type of gene | protein-coding | protein-coding | |
Description | mast/stem cell growth factor receptor Kitc-Kit protooncogenep145 c-kitpiebald trait proteinproto-oncogene c-Kitproto-oncogene tyrosine-protein kinase Kitsoluble KIT variant 1tyrosine-protein kinase Kitv-kit Hardy-Zuckerman 4 feline sarcoma viral o | homeodomain-only proteinlung cancer-associated Y proteinnot expressed in choriocarcinoma clone 1odd homeobox protein 1 | |
Modification date | 20180527 | 20180523 | |
UniProtAcc | P10721 | Q9BPY8 | |
Ensembl transtripts involved in fusion gene | ENST00000288135, | ENST00000554144, ENST00000420433, ENST00000556376, ENST00000381260, ENST00000337881, ENST00000605395, ENST00000508121, ENST00000503639, ENST00000553379, ENST00000381255, ENST00000317745, ENST00000555760, ENST00000556614, | |
Fusion gene scores | * DoF score | 6 X 5 X 4=120 | 4 X 3 X 3=36 |
# samples | 6 | 5 | |
** MAII score | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/36*10)=0.473931188332412 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: KIT [Title/Abstract] AND HOPX [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | KIT | GO:0000187 | activation of MAPK activity | 21640708 |
Hgene | KIT | GO:0002551 | mast cell chemotaxis | 20100931 |
Hgene | KIT | GO:0018108 | peptidyl-tyrosine phosphorylation | 21640708 |
Hgene | KIT | GO:0019221 | cytokine-mediated signaling pathway | 21640708 |
Hgene | KIT | GO:0031532 | actin cytoskeleton reorganization | 1721869 |
Hgene | KIT | GO:0032762 | mast cell cytokine production | 20100931 |
Hgene | KIT | GO:0038093 | Fc receptor signaling pathway | 20100931 |
Hgene | KIT | GO:0038109 | Kit signaling pathway | 17662946 |
Hgene | KIT | GO:0046777 | protein autophosphorylation | 21640708 |
Hgene | KIT | GO:0060326 | cell chemotaxis | 1721869 |
Hgene | KIT | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation | 19088079 |
Tgene | HOPX | GO:0001829 | trophectodermal cell differentiation | 17576768 |
Tgene | HOPX | GO:0045596 | negative regulation of cell differentiation | 17576768 |
Tgene | HOPX | GO:0051131 | chaperone-mediated protein complex assembly | 10811660 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LGG | TCGA-S9-A89Z-01A | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000288135 | ENST00000554144 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
Frame-shift | ENST00000288135 | ENST00000420433 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-5UTR | ENST00000288135 | ENST00000556376 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-5UTR | ENST00000288135 | ENST00000381260 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-5UTR | ENST00000288135 | ENST00000337881 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-intron | ENST00000288135 | ENST00000605395 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-intron | ENST00000288135 | ENST00000508121 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-5UTR | ENST00000288135 | ENST00000503639 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-5UTR | ENST00000288135 | ENST00000553379 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-5UTR | ENST00000288135 | ENST00000381255 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-5UTR | ENST00000288135 | ENST00000317745 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-5UTR | ENST00000288135 | ENST00000555760 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
5CDS-5UTR | ENST00000288135 | ENST00000556614 | KIT | chr4 | 55524248 | + | HOPX | chr4 | 57522178 | - |
Top |
FusionProtFeatures for KIT_HOPX |
![]() |
Hgene | Tgene |
KIT | HOPX |
Tyrosine-protein kinase that acts as cell-surfacereceptor for the cytokine KITLG/SCF and plays an essential role inthe regulation of cell survival and proliferation, hematopoiesis,stem cell maintenance, gametogenesis, mast cell development,migration and function, and in melanogenesis. In response toKITLG/SCF binding, KIT can activate several signaling pathways.Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates theAKT1 signaling pathway by phosphorylation of PIK3R1, theregulatory subunit of phosphatidylinositol 3-kinase. Activated KITalso transmits signals via GRB2 and activation of RAS, RAF1 andthe MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activationof STAT family members STAT1, STAT3, STAT5A and STAT5B. Activationof PLCG1 leads to the production of the cellular signalingmolecules diacylglycerol and inositol 1,4,5-trisphosphate. KITsignaling is modulated by protein phosphatases, and by rapidinternalization and degradation of the receptor. Activated KITpromotes phosphorylation of the protein phosphatases PTPN6/SHP-1and PTPRU, and of the transcription factors STAT1, STAT3, STAT5Aand STAT5B. Promotes phosphorylation of PIK3R1, CBL, CRK (isoformCrk-II), LYN, MAPK1/ERK2 and/or MAPK3/ERK1, PLCG1, SRC and SHC1.{ECO:0000269|PubMed:10397721, ECO:0000269|PubMed:12444928,ECO:0000269|PubMed:12511554, ECO:0000269|PubMed:12878163,ECO:0000269|PubMed:17904548, ECO:0000269|PubMed:19265199,ECO:0000269|PubMed:21135090, ECO:0000269|PubMed:21640708,ECO:0000269|PubMed:7520444, ECO:0000269|PubMed:9528781}. | Atypical homeodomain protein which does not bind DNA andis required to modulate cardiac growth and development. Acts viaits interaction with SRF, thereby modulating the expression ofSRF-dependent cardiac-specific genes and cardiac development.Prevents SRF-dependent transcription either by inhibiting SRFbinding to DNA or by recruiting histone deacetylase (HDAC)proteins that prevent transcription by SRF. Overexpression causescardiac hypertrophy (By similarity). May act as a tumorsuppressor. Acts as a co-chaperone for HSPA1A and HSPA1B chaperoneproteins and assists in chaperone-mediated protein refolding(PubMed:27708256). {ECO:0000250|UniProtKB:Q8R1H0,ECO:0000269|PubMed:27708256}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for KIT_HOPX |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for KIT_HOPX |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
KIT | BCR, CD9, CD63, CD81, GRB2, PIK3R1, PIK3R2, SOCS1, TEC, CRKL, PLCG1, INPP5D, YES1, GRB7, STAT1, CLTC, LCK, DOK1, LYN, PTPN11, JAK2, KITLG, GRB10, MATK, PTPN6, MPDZ, PTPRO, GRAP, SH3KBP1, CBLB, CBL, SOCS6, PDGFRA, SRC, CRK, IL7R, JAK3, STAT5B, PIK3CG, CSF2RA, IRF3, HSP90B1, RPS6KB1, TP53, SMO, ILKAP, PTPN20B, STYX, PIK3CA, KIT, CSF1R | HOPX | HDAC2, HOXB9, TLX3, ZSCAN1, HSP90AA1, HSPA4, EPC1, TCF12, S100A2, ASUN |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for KIT_HOPX |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | KIT | P10721 | DB00619 | Imatinib | Mast/stem cell growth factor receptor Kit | small molecule | approved |
Hgene | KIT | P10721 | DB06589 | Pazopanib | Mast/stem cell growth factor receptor Kit | small molecule | approved |
Hgene | KIT | P10721 | DB08896 | Regorafenib | Mast/stem cell growth factor receptor Kit | small molecule | approved |
Hgene | KIT | P10721 | DB00398 | Sorafenib | Mast/stem cell growth factor receptor Kit | small molecule | approved|investigational |
Hgene | KIT | P10721 | DB01254 | Dasatinib | Mast/stem cell growth factor receptor Kit | small molecule | approved|investigational |
Hgene | KIT | P10721 | DB01268 | Sunitinib | Mast/stem cell growth factor receptor Kit | small molecule | approved|investigational |
Hgene | KIT | P10721 | DB04868 | Nilotinib | Mast/stem cell growth factor receptor Kit | small molecule | approved|investigational |
Hgene | KIT | P10721 | DB08901 | Ponatinib | Mast/stem cell growth factor receptor Kit | small molecule | approved|investigational |
Hgene | KIT | P10721 | DB09078 | Lenvatinib | Mast/stem cell growth factor receptor Kit | small molecule | approved|investigational |
Hgene | KIT | P10721 | DB09103 | Ancestim | Mast/stem cell growth factor receptor Kit | biotech | approved|investigational|withdrawn |
Top |
RelatedDiseases for KIT_HOPX |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | KIT | C0080024 | Piebaldism | 7 | CTD_human;HPO;ORPHANET;UNIPROT |
Hgene | KIT | C0238198 | Gastrointestinal Stromal Tumors | 4 | CTD_human;HPO;ORPHANET;UNIPROT |
Hgene | KIT | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | KIT | C0023487 | Acute Promyelocytic Leukemia | 1 | CTD_human |
Hgene | KIT | C0024115 | Lung diseases | 1 | CTD_human |
Hgene | KIT | C0027643 | Neoplasm Recurrence, Local | 1 | CTD_human |
Hgene | KIT | C0149925 | Small cell carcinoma of lung | 1 | CTD_human |
Hgene | KIT | C0221013 | Mastocytosis, Systemic | 1 | CTD_human |
Hgene | KIT | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | KIT | C0684337 | Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 1 | CTD_human |
Hgene | KIT | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | HOPX | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |